Skip to main content
Signal8
KANEKO YASUNORI profile photo

Yasunori Kaneko

CIK: 0001277503

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Arcus Biosciences, Inc. logo
RCUS

Arcus Biosciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Arcus Biosciences, Inc. logo
    RCUS

    Arcus Biosciences, Inc.

    Jun 11, 2026
    Award(A)
    Direct
    5.7K shares-
  • Arcus Biosciences, Inc. logo
    RCUS

    Arcus Biosciences, Inc.

    Jun 10, 2025
    Award(A)
    Direct
    13.3K shares-
  • Arcus Biosciences, Inc. logo
    RCUS

    Arcus Biosciences, Inc.

    Feb 27, 2025
    Purchase(P)
    Direct
    20K shares at avg. $10.06$201K

1-3 of 3

About KANEKO YASUNORI

KANEKO YASUNORI (SEC CIK 0001277503) files insider reports with the SEC as Director of Arcus Biosciences, Inc. (RCUS).

Signal8 holds 3 ownership filings by KANEKO YASUNORI, all Form 4s, filed between Feb 27, 2025 and Jun 12, 2026. Those filings report 3 transactions, from Feb 27, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on KANEKO YASUNORI's filings is in HAYWARD, CA.

Recent filings by KANEKO YASUNORI

  • Jun 11, 2026: Grant or award of RCUS shares (Form 4, code A).
  • Jun 10, 2025: Grant or award of RCUS shares (Form 4, code A).
  • Feb 27, 2025: Open-market purchase of RCUS shares (Form 4, code P).

Other insiders filing for Arcus Biosciences, Inc. (RCUS)

How to read Form 4 transaction codes